Treatment success rate: new TB cases in Lower-middle income (World Bank)
Lower-middle income (World Bank): Treatment success rate: new TB cases was 90 in 2023. ▲ Rising
Treatment success rate: new TB cases in Lower-middle income (World Bank), 1995–2023
Source: World Health Organization, Global Health Observatory.
Analysis
In 2023, treatment success rate: new tb cases in Lower-middle income (World Bank) stood at 90. That is the highest value across all 29 years on record.
Compared with earlier readings it is up 2.3% on the previous year and up 3.4% over ten years.
Over the whole period, treatment success rate: new tb cases in Lower-middle income (World Bank) peaked at 90 in 2023 and was at its lowest, 41, in 1996.
The long-run direction has been consistently rising across the 29 years of available data.
Treatment success rate: new TB cases in Lower-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 1995 | 47 | — |
| 1996 | 41 | -12.8% |
| 1997 | 46 | +12.2% |
| 1998 | 52 | +13.0% |
| 1999 | 51 | -1.9% |
| 2000 | 58 | +13.7% |
| 2001 | 68 | +17.2% |
| 2002 | 72 | +5.9% |
| 2003 | 79 | +9.7% |
| 2004 | 80 | +1.3% |
| 2005 | 85 | +6.2% |
| 2006 | 85 | +0.0% |
| 2007 | 86 | +1.2% |
| 2008 | 86 | +0.0% |
| 2009 | 87 | +1.2% |
| 2010 | 87 | +0.0% |
| 2011 | 87 | +0.0% |
| 2012 | 87 | +0.0% |
| 2013 | 87 | +0.0% |
| 2014 | 81 | -6.9% |
| 2015 | 81 | +0.0% |
| 2016 | 78 | -3.7% |
| 2017 | 84 | +7.7% |
| 2018 | 84 | +0.0% |
| 2019 | 86 | +2.4% |
| 2020 | 86 | +0.0% |
| 2021 | 88 | +2.3% |
| 2022 | 88 | +0.0% |
| 2023 | 90 | +2.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 47.4 | 41 | 52 | 5 |
| 2000s | 78.6 | 58 | 87 | 10 |
| 2010s | 84.2 | 78 | 87 | 10 |
| 2020s | 88 | 86 | 90 | 4 |
Countries ranked near Lower-middle income (World Bank)
- 1 Saint Kitts and Nevis 100 compare
- 1 Barbados 100 compare
- 1 Tonga 100 compare
- 1 Cook Islands 100 compare
- 1 Andorra 100 compare
- 1 Samoa 100 compare
- 1 Palestine, State of 100 compare
More health data for Lower-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 7,080 (2025)
- Total tetanus - number of reported cases, gaps filled 16,092 (2025)
- Diphtheria - number of reported cases, gaps filled 20,601 (2025)
- Measles - number of reported cases, gaps filled 97,321 (2025)
- Measles - number of reported cases, annual growth rate -8.83 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -40.79 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 117.14 % change on previous year (2025)
- Diphtheria - number of reported cases 20,601 (2025)
- Total tetanus - number of reported cases 16,092 (2025)
- Pertussis - number of reported cases 7,080 (2025)
Frequently asked questions
- What is treatment success rate: new tb cases in Lower-middle income (World Bank)?
- Treatment success rate: new tb cases in Lower-middle income (World Bank) was 90 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: new tb cases recorded in Lower-middle income (World Bank)?
- The highest recorded value was 90 in 2023.
- What is the lowest treatment success rate: new tb cases recorded in Lower-middle income (World Bank)?
- The lowest recorded value was 41 in 1996.
- How does Lower-middle income (World Bank) rank for treatment success rate: new tb cases?
- Lower-middle income (World Bank) ranks 3rd out of 11 groups with data for 2023.
- Is treatment success rate: new tb cases rising or falling in Lower-middle income (World Bank)?
- Over the last ten years it is up 3.4%. The long-run trend across the full record is rising.
- Where does this Lower-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: new TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).